Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 3736 AL 3750

Current and emerging strategies for treatment of childhood dystonia

Bertucco M, Sanger TD.

J Hand Ther. 2015 Apr-Jun;28(2):185-93; quiz 194. doi: 10.1016/j.jht.2014.11.002. Epub 2014 Nov 15.

Reward processing in neurodegenerative disease

Perry DC, Kramer JH.

Neurocase. 2015 Feb;21(1):120-33. doi: 10.1080/13554794.2013.873063. Epub 2014 Jan 13.

Potential neuroprotective role of transforming growth factor β1 (TGFβ1) in the brain

Martínez-Canabal A.

Int J Neurosci. 2015 Jan;125(1):1-9. doi: 10.3109/00207454.2014.903947. Epub 2014 Apr 16.

Epigenetic regulation of memory by acetylation and methylation of chromatin: implications in neurological disorders, aging, and addiction

Sen N.

Neuromolecular Med. 2015 Jun;17(2):97-110. doi: 10.1007/s12017-014-8306-x. Epub 2014 Apr 29.

Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective

Valor LM.

Mol Neurobiol. 2015 Feb;51(1):406-23. doi: 10.1007/s12035-014-8715-8. Epub 2014 May 1.

Behavioral and neurophysiological evidence for the enhancement of cognitive control under dorsal pallidal deep brain stimulation in Huntington's disease

Beste C, Mückschel M, Elben S, J Hartmann C, McIntyre CC, Saft C, Vesper J, Schnitzler A, Wojtecki L.

Brain Struct Funct. 2015 Jul;220(4):2441-8. doi: 10.1007/s00429-014-0805-x. Epub 2014 May 31.

Mitogen-Activated Protein Kinase Phosphatase (MKP)-1 in Nervous System Development and Disease

Collins LM, Downer EJ, Toulouse A, Nolan YM.

Mol Neurobiol. 2015;51(3):1158-67. doi: 10.1007/s12035-014-8786-6. Epub 2014 Jun 24.

Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases

Tan L, Yu JT, Tan L.

Mol Neurobiol. 2015;51(3):1249-62. doi: 10.1007/s12035-014-8803-9. Epub 2014 Jun 29.

Cerebrospinal fluid shunt-induced chorea: case report and review of the literature on shunt-related movement disorders

de Gusmäo CM, Berkowitz AL, Hung AY, Westover MB.

Pract Neurol. 2015 Feb;15(1):42-4. doi: 10.1136/practneurol-2014-000913. Epub 2014 Jul 4.

PPARγ and PGC-1α as therapeutic targets in Parkinson's

Corona JC, Duchen MR.

Neurochem Res. 2015 Feb;40(2):308-16. doi: 10.1007/s11064-014-1377-0. Epub 2014 Jul 10.

Endoplasmic reticulum stress: relevance and therapeutics in central nervous system diseases

Zhang HY, Wang ZG, Lu XH, Kong XX, Wu FZ, Lin L, Tan X, Ye LB, Xiao J.

Mol Neurobiol. 2015;51(3):1343-52. doi: 10.1007/s12035-014-8813-7. Epub 2014 Jul 22.

Huntingtin interacting protein 1 as a histopathologic adjunct in the diagnosis of Merkel cell carcinoma

Marghalani S, Feller JK, Mahalingam M, Mirzabeigi M.

Int J Dermatol. 2015 Jun;54(6):640-7. doi: 10.1111/ijd.12454. Epub 2014 Jul 29.

The chaperone Grp78 in protein folding disorders of the nervous system

Moreno JA, Tiffany-Castiglioni E.

Neurochem Res. 2015 Feb;40(2):329-35. doi: 10.1007/s11064-014-1405-0. Epub 2014 Aug 9.

Exercise testing and training in people with Huntington's disease

Dawes H, Collett J, Debono K, Quinn L, Jones K, Kelson MJ, Simpson SA, Playle R, Backx K, Wasley D, Nemeth AH, Rosser A, Izardi H, Busse M.

Clin Rehabil. 2015 Feb;29(2):196-206. doi: 10.1177/0269215514540921. Epub 2014 Aug 20.

Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases

Cao L, Tan L, Jiang T, Zhu XC, Yu JT.

Mol Neurobiol. 2015 Aug;52(1):244-55. doi: 10.1007/s12035-014-8867-6. Epub 2014 Aug 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias